Latest Biotechnology Advancements News

Page 1 of 1

Avecho Boosts Trial Momentum with $2.5M Raise Ahead of Key CBD Insomnia Data

Avecho Biotechnology advances its pivotal Phase III CBD insomnia trial with 160 patients dosed and secures $2.5 million to accelerate manufacturing and regulatory efforts ahead of a 2026 interim analysis.

Ada Torres

31 Oct 2025

Top